News > Defining biological agingLeveraging aging science (geroscience) to improve older adults’ immune health

Leveraging aging science (geroscience) to improve older adults’ immune health

Author:  |  Published on: April 27, 2020  |  Last updated: May 10, 2022

Nir Barzilai

Director, Institute for Aging Research

Leveraging aging science (geroscience) to improve older adults’ immune health

Editor's choice

Empowering cells to boost energy and recovery is a winning move

Study disproves benefits of probiotics for vaginal health

How do Tour De France athletes recover so fast? Performance coach reveals the secret

9 proven ways to beat brain fog and enhance your energy

Longevity investment platform opens-up to international investors

Urolithin A research opens door to osteoarthritis relief

Popular articles

Longevity Biomedical and SPAC Denali to create Nasdaq-listed longevity biopharm company

A decade of research expands the Hallmarks of Aging from nine to twelve

Longevity investment bulletin: Juvena, eGenesis, Springs Rejuvenation and more

Petr Sramek: Now is the right time to invest in longevity

Researchers identify small molecule that restores visual function after optic nerve injury

Hypertension drug rilmenidine can extend lifespan and slow aging

More like this

The youthful side of longevity

Economy

Mark Cuban and Peter Diamandis among celebs in biggest longevity film to date: Longevity Hackers

Economy

Improving your cardiovascular health to help maintain a healthy lifestyle

Supplements

Cyclarity’s guardians are leading the battle against atherosclerosis

Biotech

Longevity medicine education at a grassroots level will effect global change

Economy

Healthy Longevity Guide – highlighting the possibilities of longevity to physicians and wellness professionals

Economy

Changing healthcare forever and funding the new longevity economy

Economy

Spermidine – the supplement making an impact

Supplements

Constructively disruptive – tackling atherosclerosis through disease reversal

Biotech

Education is key to healthy longevity at scale

Economy

Marc P Bernegger – making longevity tangible for everybody as soon as possible

Investment

Tobias Reichmuth – the longevity market starts now

Investment

Brian Kennedy – validating aging interventions and why rapamycin is the gold standard

Biotech

Charles Brenner: longevity is not a simple engineering problem

Biotech

Aubrey de Grey on longevity at scale

Features

Back to biology – Eric Verdin talks NMN and longevity supplements

Supplements